3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
3
Respiratory Aspiration
2
Prostatic Neoplasms
2
Neoplasms
2
Motor Activity
2
Lymphedema
2
Hypoventilation
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Neurotoxicity Syndromes
1
Neuralgia
1
Neoplasm Metastasis
1
Lymphoma
1
Lung Neoplasms
1
COVID-19
1
Breast Cancer Lymphedema
1
Adenomatous Polyposis Coli
1
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Tablets
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Exercise Therapy
×
1 year
×
Clear all
No trials found.